American Society of Hematology, Blood, 26(117), p. 6974-6975, 2011
DOI: 10.1182/blood-2011-05-350314
Full text: Download
In this issue of Blood, Barao and colleagues describe repopulation of Ly49G2 single-positive NK cells after congenic hematopoietic stem cell transplantation (HSCT) that appear fully functional, having tumor cytolytic capacity despite recipients lacking MHC molecules thought necessary to license them.